{"id":55741,"date":"2025-12-02T17:27:44","date_gmt":"2025-12-02T11:57:44","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=55741"},"modified":"2025-12-02T17:28:29","modified_gmt":"2025-12-02T11:58:29","slug":"invicta-diagnostic-ipo-subscription-day-2","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-subscription-day-2\/","title":{"rendered":"Invicta Diagnostic IPO Subscription Day 2"},"content":{"rendered":"<p>Here, the Invicta Diagnostic IPO launched on 1st December 2025. The bidding for the issue will close on 3rd December 2025. The primary aim of the <strong>Invicta Diagnostic IPO<\/strong> is to raise \u20b928.12 crores from the market. Also, the Invicta Diagnostic IPO has received an impressive level of subscription, indicating that the shares will be listed at an impeccable premium. Scroll down to check the Invicta Diagnostic IPO subscription and details.&nbsp;<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-subscription-day-2\/#Invicta_Diagnostic_IPO_Details\" title=\"Invicta Diagnostic IPO Details&nbsp;\">Invicta Diagnostic IPO Details&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-subscription-day-2\/#Invicta_Diagnostic_IPO_Subscription_Status\" title=\"Invicta Diagnostic IPO Subscription Status\">Invicta Diagnostic IPO Subscription Status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-subscription-day-2\/#Invicta_Diagnostic_IPO_GMP_Today\" title=\"Invicta Diagnostic IPO GMP Today\">Invicta Diagnostic IPO GMP Today<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-subscription-day-2\/#About_Invicta_Diagnostic_Ltd\" title=\"About Invicta Diagnostic Ltd.\">About Invicta Diagnostic Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-subscription-day-2\/#Invicta_Diagnostic_Limited_Financials\" title=\"Invicta Diagnostic Limited Financials\">Invicta Diagnostic Limited Financials<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-subscription-day-2\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-subscription-day-2\/#Technical_Analysis\" title=\"Technical Analysis\">Technical Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-subscription-day-2\/#Invicta_Diagnostic_IPO_Listing_Expectations\" title=\"Invicta Diagnostic IPO Listing Expectations\">Invicta Diagnostic IPO Listing Expectations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-subscription-day-2\/#Invicta_Diagnostic_IPO_Dates\" title=\"Invicta Diagnostic IPO Dates\">Invicta Diagnostic IPO Dates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-subscription-day-2\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_Details\"><\/span><strong>Invicta Diagnostic IPO Details&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>1st December 2025<\/td><\/tr><tr><td><strong>Face Value&nbsp;<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Price Band<\/strong><\/td><td>\u20b980 and \u20b985 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>1,600 shares<\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>NSE &amp; SME<\/td><\/tr><tr><td><strong>IPO Close Date&nbsp;<\/strong><\/td><td>3rd December2025<\/td><\/tr><tr><td><strong>Listing Date&nbsp;<\/strong><\/td><td>8th December 2025<\/td><\/tr><\/tbody><\/table><\/figure><p>The price band for Invicta Diagnostic&#8217;s IPO has been set at Rs 80 to Rs 85, and a total of 33,08,800 shares are being issued. Let&#8217;s segregate the share quota fixed for different categories of investors.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Categories<\/strong><\/td><td><strong>Shares Offered<\/strong><\/td><td><strong>% of shares Offered<\/strong><\/td><\/tr><tr><td><strong>Market Maker Shares Offered<\/strong><\/td><td>1,66,400<\/td><td>5.03%<\/td><\/tr><tr><td><strong>Qualified Institutional Investors<\/strong><\/td><td>13,32,800<\/td><td>40.28%<\/td><\/tr><tr><td><strong>Non-Institutional Investors<\/strong><\/td><td>5,42,400<\/td><td>16.39%<\/td><\/tr><tr><td><strong>Retail Investors<\/strong><\/td><td>12,67,200<\/td><td>38.30%<\/td><\/tr><tr><td><strong>Total Shares Offered<\/strong><\/td><td>33,08,800<\/td><td>100.00%<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_Subscription_Status\"><\/span><strong>Invicta Diagnostic IPO Subscription Status<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>As of now, the Invicta Diagnostic IPO has been subscribed to 0.95 times. Of these, 0.78&nbsp; times are subscribed by retail investors, 0.74 times by non-institutional investors, and 1.55 times by QII (Qualified Institutional Investors).&nbsp;&nbsp;<\/p><p>The healthy subscription status indicates that investors are expecting higher returns at the time of the Invicta Diagnostic IPO listing on 8th December 2025. Invicta Diagnostic also has a positive outlook on the fresh issue of 33,00,000 shares, which is expected to raise around Rs 28.12 crores.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_GMP_Today\"><\/span><strong>Invicta Diagnostic IPO GMP Today<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02172520\/Invicta-Diagnostic-IPO-GMP-1-1-1024x536.jpg\" alt=\"Invicta Diagnostic IPO GMP\n\" class=\"wp-image-55743\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02172520\/Invicta-Diagnostic-IPO-GMP-1-1-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02172520\/Invicta-Diagnostic-IPO-GMP-1-1-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02172520\/Invicta-Diagnostic-IPO-GMP-1-1-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02172520\/Invicta-Diagnostic-IPO-GMP-1-1-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02172520\/Invicta-Diagnostic-IPO-GMP-1-1-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02172520\/Invicta-Diagnostic-IPO-GMP-1-1-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02172520\/Invicta-Diagnostic-IPO-GMP-1-1.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>We know that higher subscription levels drive grey-market premiums for IPOs. Let\u2019s explore the Invicta Diagnostic IPO GMP for 1st December 2025.&nbsp;<\/p><p>The grey market premium for this IPO has surged to 0.00% or Rs 0 per share. It indicates that the estimated listing price per share is Rs 85. Numerous factors played a pivotal role in this jump in Invicta Diagnostic&#8217;s IPO GMP. These include higher subscription rates, favourable market sentiment, and investors&#8217; positive attitude towards IPOs.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>GMP Date<\/strong><\/td><td><strong>IPO Price<\/strong><\/td><td><strong>GMP<\/strong><\/td><td><strong>Estimated Listing Price&nbsp;<\/strong><\/td><td><strong>Estimated Listing Gains<\/strong><\/td><\/tr><tr><td><strong>2-12-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>1-12-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>30-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>29-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>28-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>27-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>26-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Invicta_Diagnostic_Ltd\"><\/span><strong>About Invicta Diagnostic Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Invicta Diagnostics was established in January 2021. Invicta Diagnostic Limited offers radiology and pathology solutions. The company provides pathology and radiology testing, including imaging, radiology, and teleradiology, under the brand &#8216;PC Diagnostics&#8217; through 7 diagnostic centres and a central laboratory across Mumbai, Maharashtra. Invicta Diagnostics\u202fLimited (trading as PC Diagnostics) is a Mumbai-based diagnostic services company specialising in integrated pathology and radiology solutions. The company follows a hub\u2011and\u2011spoke model across the Mumbai Metropolitan Region, featuring:<\/p><ol class=\"wp-block-list\"><li>Flagship Hub<\/li>\n\n<li>Three additional hubs are Bhayandar, Byculla, and Marol<\/li>\n\n<li>Three spokes in Lower Parel, Sewri and Kalwa<\/li><\/ol><p>The company offers around 60 routine and 487 specialised pathology tests, plus about 96 basic and 130 advanced radiology tests.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_Limited_Financials\"><\/span><strong>Invicta Diagnostic Limited Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The company&#8217;s financial analysis is essential before applying for the<strong> Invicta Diagnostic IPO. <\/strong>Look at the table to learn about Invicta Diagnostic&nbsp; Limited&#8217;s financials.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Year Ended<\/strong><\/td><td><strong>30th September 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2024 (in cr.)<\/strong><\/td><\/tr><tr><td><strong>Assets<\/strong><\/td><td>34.90<\/td><td>21.22<\/td><td>15.89<\/td><\/tr><tr><td><strong>Revenue<\/strong><\/td><td>17.08<\/td><td>30.18<\/td><td>15.90<\/td><\/tr><tr><td><strong>Profit After Tax<\/strong><\/td><td>4.08<\/td><td>4.93<\/td><td>3.81<\/td><\/tr><tr><td><strong>EBITDA<\/strong><\/td><td>6.77<\/td><td>9.20<\/td><td>7.09<\/td><\/tr><tr><td><strong>Net Worth<\/strong><\/td><td>23.68<\/td><td>13.60<\/td><td>8.67<\/td><\/tr><tr><td><strong>Reserves and Surplus<\/strong><\/td><td>14.42<\/td><td>5.18<\/td><td>8.54<\/td><\/tr><tr><td><strong>Total Borrowing<\/strong><\/td><td>3.72<\/td><td>3.54<\/td><td>3.81<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Invicta Diagnostic&nbsp; Limited&#8217;s revenue soared by 90% from \u20b915.90 crores in March 2024&nbsp; to \u20b930.18 crores in March 2025. Moreover, the company&#8217;s PAT increased by 30% from \u20b93.81 crores in March 2024 to \u20b94.93 crores in March 2025.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Technical_Analysis\"><\/span><strong>Technical Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Several technical indicators are available to assess a company&#8217;s potential to deliver returns. Use the parameters mentioned below to analyse the technicals of the <strong>Invicta Diagnostic IPO<\/strong>.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Key Indicators<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/price-to-earnings-ratio-p-e-ratio\"><strong>PE Ratio (Price-to-Earnings)<\/strong><\/a><strong>&nbsp;<\/strong><\/td><td>15.97<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\"><strong>EPS (Earnings Per Share)<\/strong><\/a><\/td><td>5.32<\/td><\/tr><tr><td><strong>RoNW<\/strong><\/td><td>36.25%<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/return-on-capital-employed\"><strong>ROCE<\/strong><\/a><\/td><td>42.00%<\/td><\/tr><tr><td><strong>ROE<\/strong><\/td><td>44.28%<\/td><\/tr><tr><td><strong>EBITDA Margin<\/strong><\/td><td>30.57%<\/td><\/tr><tr><td><strong>Price to Book Value<\/strong><\/td><td>5.26<\/td><\/tr><tr><td><strong>Market Capitalisation<\/strong><\/td><td>\u20b9106.86 Cr.<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_Listing_Expectations\"><\/span><strong>Invicta Diagnostic IPO Listing Expectations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Invicta Diagnostic Highlights: IPO allotment is still pending, as the bid will close today. However, given the current GMP or market sentiment, it is reasonable to expect higher listing gains for the share. A 0.00% jump in Yash Highlight GMP suggests the estimated listing price per share will be around Rs 85.<\/p><p>It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts\u2019 top long-term recommendation.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_Dates\"><\/span><strong>Invicta Diagnostic IPO Dates<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>1st December 2025<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>3rd December 2025<\/td><\/tr><tr><td><strong>Allotment<\/strong><\/td><td>4th December 2025<\/td><\/tr><tr><td><strong>Refund Date<\/strong><\/td><td>5th December 2025<\/td><\/tr><tr><td><strong>IPO Listing Date<\/strong><\/td><td>8th December 2025<\/td><\/tr><\/tbody><\/table><\/figure><p><strong>Note<\/strong>: IPO GMP is volatile and depends on market sentiment. Hence, one should conduct their research before investing in it.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/iicodex-publishing-solutions-ipo-gmp\">Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/bluestone-jewellery-ipo-gmp\">Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/highway-infrastructure-ipo-listing-preview\">Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/concord-biotech-q1-results-fy26\">Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to \u20b944.06 Crore; Revenue Down 5.47% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/action-construction-equipment-q1-results-fy26\">Action Construction Equipment Q1 Results FY26: Q1 PAT Rises 16.08% to \u20b997.72 Crore; Revenue Down 11.19% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/sawaliya-foods-products-ipo-allotment-status\">Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/jsw-cement-ipo-allotment-status\">Invicta Diagnostic IPO Allotment Status Check Online: GMP, Subscription, Price, and More<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/mahendra-realtors-ipo\">Mahendra Realtors IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/regaal-resources-ipo\">Regaal Resources IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/icodex-publishing-solutions-ipo\">Icodex Publishing Solutions IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Here, the Invicta Diagnostic IPO launched on 1st December 2025. The bidding for the issue will close on 3rd December 2025. The primary aim of the Invicta Diagnostic IPO is to raise \u20b928.12 crores from the market. Also, the Invicta Diagnostic IPO has received an impressive level of subscription, indicating that the shares will be<\/p>\n","protected":false},"author":23,"featured_media":55742,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[3579],"class_list":["post-55741","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-invicta-diagnostic-ipo-subscription"],"metadata":{"_edit_lock":["1764676709:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"amazonS3_cache":["a:4:{s:82:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/12\/Invicta-Diagnostic-IPO-GMP-1-1.jpg\";a:2:{s:2:\"id\";i:55743;s:11:\"source_type\";s:13:\"media-library\";}s:91:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/12\/Invicta-Diagnostic-IPO-GMP-1-1-1024x536.jpg\";a:2:{s:2:\"id\";i:55743;s:11:\"source_type\";s:13:\"media-library\";}s:114:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02172520\/Invicta-Diagnostic-IPO-GMP-1-1.jpg\";a:2:{s:2:\"id\";i:55743;s:11:\"source_type\";s:13:\"media-library\";}s:123:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02172520\/Invicta-Diagnostic-IPO-GMP-1-1-1024x536.jpg\";a:2:{s:2:\"id\";i:55743;s:11:\"source_type\";s:13:\"media-library\";}}"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["78"],"rank_math_title":["Invicta Diagnostic IPO Subscription Status Day 2: Check Online"],"rank_math_description":["Check the Invicta Diagnostic IPO subscription status online and also get live GMP details and reviews to anticipate the listing gains. Explore for further information about the Invicta Diagnostic IPO. \r\n"],"rank_math_focus_keyword":["Invicta Diagnostic IPO"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["55742"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["4919"],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/invicta-diagnostic-ipo-subscription-day-2"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/02172234\/Invicta-Diagnostic-IPO-Subscription-Status-Day-2.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55741","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=55741"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55741\/revisions"}],"predecessor-version":[{"id":55744,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55741\/revisions\/55744"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/55742"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=55741"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=55741"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=55741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}